您当前的位置：
首页 >
文章列表页 >
Signals mining and analysis of inebilizumab adverse events
更新时间：2026-01-24

    • Signals mining and analysis of inebilizumab adverse events

    • “The latest research reveals adverse event signals of Inalizumab, providing reference for safe clinical medication. Research has found that Inalizumab may pose potential risks such as B cell recovery and vertebral compression fractures.”
    • ZHONGGUO YAOFANG   Vol. 37, Issue 2, Pages: 215-219(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.02.14    

      CLC： R979.5;R744.3

    • Received：16 September 2025，

      Revised：2025-10-19，

      Accepted：26 December 2025，

      Published：30 January 2026

    移动端阅览

  • ZHANG Jiayi,LIU Chen,ZHANG Xiaotong.Signals mining and analysis of inebilizumab adverse events[J].ZHONGGUO YAOFANG,2026,37(02):215-219. DOI： 10.6039/j.issn.1001-0408.2026.02.14.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0